Intraneuronal β-amyloid impaired mitochondrial proteostasis through the impact on LONP1
Open Access
- 13 December 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (51)
Abstract
Mitochondrial dysfunction plays a critical role in the pathogenesis of Alzheimer’s disease (AD). Mitochondrial proteostasis regulated by chaperones and proteases in each compartment of mitochondria is critical for mitochondrial function, and it is suspected that mitochondrial proteostasis deficits may be involved in mitochondrial dysfunction in AD. In this study, we identified LONP1, an ATP-dependent protease in the matrix, as a top Aβ42 interacting mitochondrial protein through an unbiased screening and found significantly decreased LONP1 expression and extensive mitochondrial proteostasis deficits in AD experimental models both in vitro and in vivo, as well as in the brain of AD patients. Impaired METTL3-m 6 A signaling contributed at least in part to Aβ42-induced LONP1 reduction. Moreover, Aβ42 interaction with LONP1 impaired the assembly and protease activity of LONP1 both in vitro and in vivo. Importantly, LONP1 knockdown caused mitochondrial proteostasis deficits and dysfunction in neurons, while restored expression of LONP1 in neurons expressing intracellular Aβ and in the brain of CRND8 APP transgenic mice rescued Aβ-induced mitochondrial deficits and cognitive deficits. These results demonstrated a critical role of LONP1 in disturbed mitochondrial proteostasis and mitochondrial dysfunction in AD and revealed a mechanism underlying intracellular Aβ42-induced mitochondrial toxicity through its impact on LONP1 and mitochondrial proteostasis.Keywords
Funding Information
- HHS | National Institutes of Health (R01AG076917)
- HHS | National Institutes of Health (R03AG063362)
- Alzheimer's Association (AARG-21-852438)
- HHS | National Institutes of Health (NS083498)
- HHS | National Institutes of Health (AG049479)
- HHS | National Institutes of Health (AG083811)
This publication has 56 references indexed in Scilit:
- Distinct quaternary structures of the AAA+ Lon protease control substrate degradationProceedings of the National Academy of Sciences, 2013
- Perrault Syndrome Is Caused by Recessive Mutations in CLPP, Encoding a Mitochondrial ATP-Dependent Chambered ProteaseThe American Journal of Human Genetics, 2013
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012
- The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivativesBlood, 2012
- Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's DiseasePLOS ONE, 2012
- Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairmentJournal of Bioenergetics and Biomembranes, 2009
- Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's DiseaseThe Journal of Neuroscience, 2009
- Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's diseaseNature Medicine, 2008
- The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristaeProceedings of the National Academy of Sciences, 2008
- Human Mitochondrial ClpP Is a Stable Heptamer That Assembles into a Tetradecamer in the Presence of ClpXJournal of Biological Chemistry, 2005